Savara, Inc. (SVRA)
4.72
-0.27
(-5.41%)
USD |
NASDAQ |
Nov 12, 16:00
4.79
+0.07
(+1.48%)
After-Hours: 20:00
Savara Price to Book Value : 8.995 for Nov. 12, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 8.995 |
| November 11, 2026 | 9.510 |
| November 10, 2026 | 9.376 |
| November 09, 2026 | 9.624 |
| November 06, 2026 | 9.205 |
| November 05, 2026 | 8.347 |
| November 04, 2026 | 8.881 |
| November 03, 2026 | 9.052 |
| November 02, 2026 | 9.014 |
| October 30, 2026 | 9.186 |
| October 29, 2026 | 9.433 |
| October 28, 2026 | 9.567 |
| October 27, 2026 | 9.262 |
| October 26, 2026 | 8.614 |
| October 23, 2026 | 8.042 |
| October 22, 2026 | 8.652 |
| October 21, 2026 | 8.900 |
| October 20, 2026 | 9.071 |
| October 19, 2026 | 8.824 |
| October 16, 2026 | 8.481 |
| October 15, 2026 | 9.033 |
| October 14, 2026 | 9.071 |
| October 13, 2026 | 9.109 |
| October 12, 2026 | 9.224 |
| October 09, 2026 | 9.376 |
| Date | Value |
|---|---|
| October 08, 2026 | 9.205 |
| October 07, 2026 | 9.30 |
| October 06, 2026 | 8.862 |
| October 05, 2026 | 9.109 |
| October 02, 2026 | 9.167 |
| October 01, 2026 | 9.614 |
| September 30, 2026 | 9.834 |
| September 29, 2026 | 7.263 |
| September 28, 2026 | 7.249 |
| September 25, 2026 | 7.149 |
| September 24, 2026 | 7.249 |
| September 23, 2026 | 7.149 |
| September 22, 2026 | 7.578 |
| September 21, 2026 | 7.792 |
| September 18, 2026 | 7.678 |
| September 17, 2026 | 7.749 |
| September 16, 2026 | 7.335 |
| September 15, 2026 | 7.520 |
| September 14, 2026 | 7.635 |
| September 11, 2026 | 7.578 |
| September 10, 2026 | 7.606 |
| September 09, 2026 | 7.742 |
| September 08, 2026 | 7.907 |
| September 04, 2026 | 7.678 |
| September 03, 2026 | 7.678 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.259 |
| Alnylam Pharmaceuticals, Inc. | 5.819 |
| Anika Therapeutics, Inc. | 1.344 |
| Vericel Corp. | 7.629 |
| Biogen, Inc. | 1.956 |
Price to Book Value Related Metrics
| PEG Ratio | -0.5603 |
| Price | 4.72 |
| Earnings Yield | -12.90% |
| Market Cap | 970.13M |
| PEGY Ratio | -0.5603 |